ScanSource (SCSC) Stock Falls Despite Record EPS And Cash Flow

ScanSource stock closed down about 3.5% today, even though the latest quarter landed with the kind of punch long term holders usually want to see. The distributor posted Q4 revenue of US$953.1m and basic earnings per share of US$1.26, capping a year in which trailing earnings moved higher and valuation multiples stayed below peers.

In the very short term traders focused on the red on the screen. Over a multi year lens the bigger story is a record non GAAP earnings print, rising recurring revenue and a P/E that still sits at a discount to the wider electronics group.

Like the earnings strength at ScanSource but want more companies where profits, recurring revenue and valuation all line up cleanly? Check out our 19 high quality undiscovered gems for a focused list that shares similar fundamentals with additional potential.

Q4 2026 Earnings Summary

• Revenue (Q4 2026 vs. Q4 2025): US$953.1m vs. US$812.9m (up about 17%)
• Net Income (Excl. Extra Items, Q4 2026 vs. Q4 2025): US$25.6m vs. US$20.1m (up about 27%)
• Basic EPS (Q4 2026 vs. Q4 2025): US$1.26 vs. US$0.89 (up about 41%)
• Net Profit Margin (Trailing 12 Months vs. Prior Year): 2.4% vs. 2.4% (slightly higher year over year according to management commentary)

Prefer clear charts instead of scrolling through another wall of earnings tables and ratios? Get a full visual read on ScanSource with an at a glance view of its valuation in the company report for ScanSource.

ScanSource bull case leans on recurring and cash

Bulls argue ScanSource is proving it can shift from hardware to recurring, higher margin offerings while keeping cash generation strong. The quarter gives some solid proof points. Recurring revenue grew 10.6% for FY26 and recurring gross profit reached 34% of the total, which supports the idea of a more durable earnings base. Specialty Technology Solutions still has recurring at about 15% of segment gross profit, so the mix shift remains a work in progress rather than complete. Record non GAAP EPS in Q4 and free cash flow of US$114m, equal to 124% of non GAAP net income, back up the claim that earnings quality and cash conversion align. The MicroAge deal, if it closes as planned by Q1 FY27, would add more cloud and cybersecurity exposure, which fits the thesis that services and software will matter more over time.

Bear case focuses on hardware, execution and reaction

Bears focus on three issues: hardware dependence, execution risk on acquisitions and the share price reaction. Hardware still drives most revenue and Specialty Technology Solutions margins remain below Intelisys & Advisory, which fits the concern that a hardware heavy mix could cap profitability if service uptake slows. The MicroAge acquisition is material relative to ScanSource and management itself flags integration and channel conflict as real risks, which aligns with worries that M&A could strain execution. Guidance for FY27 calls for 6% to 10% organic revenue growth and adjusted EBITDA margins around 4.6% to 4.65%. That does not yet show a step change in profitability. Finally, the stock fell about 3.5% on the day of the report after strong headline numbers, which suggests some investors still question how repeatable this earnings strength and M&A driven story will be.

With ScanSource still reliant on hardware and planning a material acquisition, the key question is whether cash generation and the balance sheet comfortably back that story. Check the full solvency breakdown in our financial health analysis of ScanSource stock.

Take Control Of Your Next Move

If the mix of recurring growth, cash generation and MicroAge acquisition plans at ScanSource has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for your preferred entry point. After you build a position, use the Portfolio Command Center to keep your holdings organized and filter for only the most important developments. For a broader view of how other investors are thinking about opportunities like ScanSource, join the discussion inside the Community. Spot potential catalysts and risks earlier so you can act with confidence before the wider market reacts.

Seeking Alternatives Beyond ScanSource Now

Some stocks are building quiet momentum while others are dropping out of favor. Fresh ideas get picked over fast, so review these under the radar opportunities before the crowd and consider acting while they remain less noticed.

• Chase early income potential from established businesses by reviewing the 12 dividend fortresses that filters for higher yields while they are still under the radar.
• Spot underfollowed compounding stories with strong balance sheets through the curated list of solid balance sheet and fundamentals stocks (50 results) before more investors consider later entries.
• Follow structural themes with less hype by scanning the 39 power grid technology and infrastructure stocks and find infrastructure stocks that may be gaining momentum while it still matters.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com